submitted 5 months ago by [email protected] to c/[email protected]

6 comments fedilink hide all child comments

Exclusive: A U.S. lawmaker involved in health policy has asked the Food and Drug Administration why it did not inspect Elon #Musk's Neuralink before allowing the brain implant company to test its device in humans. https://www.reuters.com/business/healthcare-pharmaceuticals/us-lawmaker-seeks-answers-fda-inspection-musks-neuralink-2024-03-26/

top 6 comments

sorted by: hot top controversial new old

[-] [email protected] 1 points 5 months ago

@[email protected]
I think the FDA is ill equipped to be the Tech Admin.

Their answer should have been "umm no. You're thousands of living monkeys away from human testing"

[-] [email protected] 1 points 5 months ago

@[email protected] That is a very good question - the Human Subject Research regulations prohibit that

[-] [email protected] 1 points 5 months ago

@[email protected]

Yep. The rest of the medical community would like to know that, as well.

[-] [email protected] 0 points 5 months ago

@GottaLaff
Lots of questions

[-] [email protected] 0 points 5 months ago

@mloxton We need lots of answers.

[-] [email protected] 1 points 5 months ago

@[email protected]
I think I know the answer to the main question, and it is a bit boring.

I expect that Neuralink got approval for human testing because they used a "same as" application, and could cite many other very similar implants that had been previously approved for other applicants. (2002, 2006, etc)

I want to know how this patient selected, the end points, what is this "issue" that the patient mentioned, what outcomes and adverse effects are being monitored, what are the rollback options?

this post was submitted on 26 Mar 2024

1 points (100.0% liked)

Random stuff

1 readers

1 users here now

founded 1 year ago

MODERATORS

[email protected]